Essama Telli: When a Bruise Doesn’t Heal – Recognising the Warning Signs
Essama Telli, Dermatologist at IUCT-Oncopole, shared a post on LinkedIn:
“The bruise that doesn’t disappear. When should we investigate?
A patient comes back because the bruise is still there. Two questions can help guide the next step. Has it changed since the last visit? What can I feel beneath it?
If there’s a lump, document its size, depth and interval growth. Reassess a presumed haematoma that persists beyond about a month. An unexplained lump that is enlarging warrants earlier assessment.
NICE recommends considering urgent ultrasound in adults and a suspected cancer referral if the scan is suspicious or if the findings are uncertain and clinical concern persists.
If the bruising is spontaneous or recurrent, ask about epistaxis, heavy menstrual bleeding, bleeding after procedures, family history and medication use. Initial tests include a CBC with platelet count, peripheral smear, PT/INR, aPTT and fibrinogen.
A convincing bleeding history can warrant von Willebrand testing even when PT and aPTT are normal. New spontaneous soft-tissue bleeding with an isolated prolonged aPTT warrants urgent discussion with haematology about acquired haemophilia A.
If it’s an expanding violaceous plaque, particularly on the scalp or face of an older adult, look for induration, nodules or ulceration. Cutaneous angiosarcoma is rare, but it can resemble a bruise. A progressive lesion with those features merits prompt dermatology assessment for biopsy.
At follow-up, write down what changed.’Still purple’ tells you less than ‘larger, firmer and extending beyond the original border.’ ”
Title: Soft Tissue Masses: Evaluation and Treatment
Authors: Suraj Achar, Jarrod Yamanaka, Jennifer Oberstar
Read the Full Article on American Family Physician

Title: Bleeding and Bruising: Primary Care Evaluation
Authors: Pamela R Hughes, Meghan N Lewis, Shalease S Adams
Read the Full Article on American Family Physician

Title: ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease
Authors: Paula D James, Nathan T Connell, Barbara Ameer, Jorge Di Paola, Jeroen Eikenboom, Nicolas Giraud, Sandra Haberichter, Vicki Jacobs-Pratt, Barbara Konkle, Claire McLintock, Simon McRae, Robert R Montgomery, James S O’Donnell, Nikole Scappe, Robert Sidonio Jr, Veronica H Flood, Nedaa Husainat, Mohamad A Kalot, Reem A Mustafa
Read the Full Article on Blood Advances

Title: International recommendations on the diagnosis and treatment of acquired hemophilia A
Authors: Andreas Tiede, Peter Collins, Paul Knoebl, Jerome Teitel, Craig Kessler, Midori Shima, Giovanni Di Minno, Roseline d’Oiron, Peter Salaj, Victor Jiménez-Yuste, Angela Huth-Kühne, Paul Giangrande
Read the Full Article on Haematologica

Title: A Novel Presentation of Cutaneous Angiosarcoma: A Case Report and Review
Authors: Sonali Bajaj, Prafulla Kumar Sharma, Imroz Singh Sachdev, Minakshi Bhardhwaj
Read the Full Article on Indian Journal Medical and Paediatric Oncology

Stay updated with Hemostasis Today.
-
Nov 19, 2026, 12:34Edward Lee Carter: Are We Ready for FXIa Inhibitors?
-
Nov 19, 2026, 11:51Wolfgang Miesbach: Beyond Episomal Gene Therapy in Haemophilia B
-
Nov 19, 2026, 11:18A First Look at WFH CCS 2027
-
Nov 19, 2026, 10:58Does a Higher Measured Factor Level Always Mean Better Protection Against Joint Bleeds? – Global Hemophilia Report
-
Nov 19, 2026, 10:43Strengthening Plasma Management and Patient Access Across Eastern Europe – ISBT
-
Nov 19, 2026, 10:32Rana Al-Hrout: The Hemodilution Trap – Accurate Blast Assessment in Bone Marrow Biopsies
-
Nov 19, 2026, 10:29Maria Panagiota Terzi: Presenting Research on Coagulation Biomarkers in Acute Myocardial Infarction
-
Nov 19, 2026, 10:21Paola Ranalli: Hemophilia and von Willebrand Disease Advancing Care Through Multidisciplinary Collaboration
-
Nov 19, 2026, 10:11Rana Al-Hrout: Iron Deficiency in Heart Failure – Does It Matter Even Without Anemia?